BioSpace News Archive

Moderna, Inc. today announced that John Mendlein, Ph.D., President of Corporate and Product Strategy, will be leaving the Company effective February 1, 2019 to join Flagship Pioneering as an Executive Partner. He will be a strategic consultant to Moderna for six months to ensure a smooth transition.

Downloadable toolkit educates around the proper planning and care required for healthy pregnancies and healthy babies

The Georgia Mesothelioma Victims Center says, “If you are a US Navy Veteran who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer and you live in Georgia or you are their family member please call us anytime at 800-714-0303 so at a minimum you can receive incredibly honest advice about what specific mesothelioma attorneys you should be talking to.

Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of an underwritten public offering of 4,215,000 shares of its common stock at a public offering price of $9.50 per share,

Over 1 million total hip and total knee replacement procedures are performed each year in the United States1.

Vice President Mike Pence will be headline speaker at the 37th Annual Rose Dinner representing the Trump administration at the annual March for Life’s concluding event in Washington, DC.

4TH SPACE, a dynamic lab and immersive venue designed to bring knowledge and ideas to life, officially opened today on Concordia University’s downtown campus

The global blood group typing market is expected to post a CAGR of nearly 10% during 2019-2023, according to the latest market research report by Technavio.

The global epidermolysis bullosa therapeutics market is expected to post a CAGR of nearly 5% during the period 2019-2023, according to the latest market research report by Technavio.

- Celgene gains exclusive options to two Kyn therapeutic programs